Trial Profile
A Phase I/II Open Label Study of Nitazoxanide (NTZ) for the Treatment of Cryptosporidium Parvum in HIV Infected Infants, Children, and Adolescents
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 May 2014
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Cryptosporidiosis
- Focus Adverse reactions; Pharmacokinetics
- 10 May 2014 New trial record